Variant form of hairy cell leukemia

Mature lymphoid B‐cell proliferations with hairy cells represent heterogeneous entities where specific diagnosis is difficult but important since it impacts therapeutic management. The clinical cases of variant hairy cell leukemia reported herein illustrate the persistence of a clear interest in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiber, Margaux, Maitre, Elsa, Cornet, Edouard, Salaün, Véronique, Naguib, Dina, Troussard, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552962/
https://www.ncbi.nlm.nih.gov/pubmed/31183086
http://dx.doi.org/10.1002/ccr3.2176
_version_ 1783424709496406016
author Wiber, Margaux
Maitre, Elsa
Cornet, Edouard
Salaün, Véronique
Naguib, Dina
Troussard, Xavier
author_facet Wiber, Margaux
Maitre, Elsa
Cornet, Edouard
Salaün, Véronique
Naguib, Dina
Troussard, Xavier
author_sort Wiber, Margaux
collection PubMed
description Mature lymphoid B‐cell proliferations with hairy cells represent heterogeneous entities where specific diagnosis is difficult but important since it impacts therapeutic management. The clinical cases of variant hairy cell leukemia reported herein illustrate the persistence of a clear interest in the use of splenectomy as a therapeutic alternative. Furthermore, ibrutinib appears to be a promising treatment in patients with relapsed/refractory disease.
format Online
Article
Text
id pubmed-6552962
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65529622019-06-10 Variant form of hairy cell leukemia Wiber, Margaux Maitre, Elsa Cornet, Edouard Salaün, Véronique Naguib, Dina Troussard, Xavier Clin Case Rep Case Reports Mature lymphoid B‐cell proliferations with hairy cells represent heterogeneous entities where specific diagnosis is difficult but important since it impacts therapeutic management. The clinical cases of variant hairy cell leukemia reported herein illustrate the persistence of a clear interest in the use of splenectomy as a therapeutic alternative. Furthermore, ibrutinib appears to be a promising treatment in patients with relapsed/refractory disease. John Wiley and Sons Inc. 2019-05-06 /pmc/articles/PMC6552962/ /pubmed/31183086 http://dx.doi.org/10.1002/ccr3.2176 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Wiber, Margaux
Maitre, Elsa
Cornet, Edouard
Salaün, Véronique
Naguib, Dina
Troussard, Xavier
Variant form of hairy cell leukemia
title Variant form of hairy cell leukemia
title_full Variant form of hairy cell leukemia
title_fullStr Variant form of hairy cell leukemia
title_full_unstemmed Variant form of hairy cell leukemia
title_short Variant form of hairy cell leukemia
title_sort variant form of hairy cell leukemia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552962/
https://www.ncbi.nlm.nih.gov/pubmed/31183086
http://dx.doi.org/10.1002/ccr3.2176
work_keys_str_mv AT wibermargaux variantformofhairycellleukemia
AT maitreelsa variantformofhairycellleukemia
AT cornetedouard variantformofhairycellleukemia
AT salaunveronique variantformofhairycellleukemia
AT naguibdina variantformofhairycellleukemia
AT troussardxavier variantformofhairycellleukemia

Ejemplares similares